These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 13180246)

  • 1. Beta-Naphthyl-di-chloroethylamine in the treatment of malignant diseases, particularly Hodgkin's disease.
    VIDEBAEK A; KAAE S
    Acta Med Scand; 1954; 149(5):361-8. PubMed ID: 13180246
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indication of the use of beta-naphthyl-di-2-chloroethylamine, in Hodgkin's disease and Leukemia].
    RAMIOUL H
    Acta Unio Int Contra Cancrum; 1955; 11(2):167-9. PubMed ID: 13248724
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic results in treatment of Hodgkin's disease with CB 1348 and R-48.
    ROTTINO A
    Blood; 1957 Aug; 12(8):755-65. PubMed ID: 13446003
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new derivative of yperite for oral and intramuscular administration: bis-(2-chloroethyl) beta-naphthylamine in cancer].
    RAMIOUL H
    Acta Clin Belg; 1954; 9(5):401-63. PubMed ID: 13217644
    [No Abstract]   [Full Text] [Related]  

  • 5. Immediate and remote results of chloroethylamine treatment of Hodgkin's disease.
    LARIONOV LF
    Br Med J; 1956 Feb; 1(4961):252-6. PubMed ID: 13276690
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of Hodgkin's disease with naphthyl amine compounds].
    CALARESU I
    Athena; 1952 Feb; 18(2):71-4. PubMed ID: 14915930
    [No Abstract]   [Full Text] [Related]  

  • 7. Trial of beta-naphthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders.
    GARDIKAS C; WILKINSON JF
    Lancet; 1951 Jan; 1(6647):137-9. PubMed ID: 14795794
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with nitrogen mustard in Hodgkin's disease.
    BOLAND J
    Br J Radiol; 1951 Sep; 24(285):513-5. PubMed ID: 14879007
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of malignant granuloma with nitrogen mustard].
    WISNIEWSKI B
    Pol Tyg Lek (Wars); 1952 Jun; 7(23):752-7. PubMed ID: 12993604
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathologic anatomy and physiology of Hodgkin's disease treated with nitrogen mustard].
    BILLERBECK K
    Zentralbl Allg Pathol; 1951 Nov; 88(1-2):24-36. PubMed ID: 14914076
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of nitrogen mustard in the treatment of malignant lymphogranuloma].
    CROIZAT P; PAPILLON J; PINET F
    J Radiol Electrol Arch Electr Medicale; 1953; 34(1-2):83-4. PubMed ID: 13085392
    [No Abstract]   [Full Text] [Related]  

  • 12. [Histopathological aspect of the lymph nodes in Hodgkin's disease treated with nitrogen mustards].
    GENIS GALVEZ JM; CASALLA CHACON JM
    Med Colon; 1953 Jun; 21(6):652-68. PubMed ID: 13098709
    [No Abstract]   [Full Text] [Related]  

  • 13. A quantitative evaluation of the contribution of nitrogen mustard to the therapeutic management of Hodgkin's disease.
    GELLHORN A; COLLINS VP
    Ann Intern Med; 1951 Dec; 35(6):1250-9. PubMed ID: 14895004
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of Hodgkin's diseases].
    BERNARD J
    Sem Hop; 1953 Jun; 29(40):2043-4. PubMed ID: 13089718
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of x-rays and nitrogen mustards in the treatment of Hodgkin's disease].
    PIEMONTE M
    J Radiol Electrol Arch Electr Medicale; 1953; 34(1-2):80-2. PubMed ID: 13085391
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of x-rays and nitrogen mustard in the therapy of Hodgkin's disease].
    PIEMONTE
    J Med Lyon; 1952 Oct; 33(787):917-22. PubMed ID: 13023228
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of nitrogen mustard in the therapy of malignant lymphogranulomatosis].
    CROIZAT P; PAPILLON J; PINET F
    J Med Lyon; 1952 Oct; 33(787):923-6. PubMed ID: 13023229
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beta-Naphthyl-di-chlorethylamine therapy of malignant conditions, especially Hodgkin's disease].
    VIDEBAEK AA; KAAE S
    Ugeskr Laeger; 1954 Jun; 116(25):943-7. PubMed ID: 13187718
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nitrogen mustard therapy of various cases of malignant lymphogranuloma and lymphosarcoma].
    NARDI FL
    Accad Medica; 1952 Apr; 67(4):169-77. PubMed ID: 12984986
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic results with nitrogen mustards].
    LEIBETSEDER F; RABL I
    Klin Med Osterr Z Wiss Prakt Med; 1951 Nov; 6(11):521-6. PubMed ID: 14918395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.